SLPI and infection: Previous studies (32–34) have confirmed that saliva contains secretory leukocyte protease inhibitor (SLPI), which can inhibit HIV-1 activity, especially in the early infection stage, that is, the body produces protease as a protective mechanism against the virus to maintain oral functions.